Estrogen replacement therapy/Related Articles: Difference between revisions
Jump to navigation
Jump to search
imported>Robert Badgett (New related articles page generated using Special:MetadataForm) |
No edit summary |
||
| Line 17: | Line 17: | ||
==Other related topics== | ==Other related topics== | ||
<!-- List topics here that are related to this topic, but neither wholly include it nor are wholly included by it. --> | <!-- List topics here that are related to this topic, but neither wholly include it nor are wholly included by it. --> | ||
==Articles related by keyphrases (Bot populated)== | |||
{{r|Vitamin D deficiency}} | |||
{{r|Breast cancer}} | |||
{{r|Hydroxymethylglutaryl-coenzyme A reductase inhibitor}} | |||
{{r|Coronary heart disease}} | |||
Latest revision as of 16:00, 13 August 2024
- See also changes related to Estrogen replacement therapy, or pages that link to Estrogen replacement therapy or to this page or whose text contains "Estrogen replacement therapy".
Parent topics
Subtopics
- Vitamin D deficiency [r]: Vitamin D deficiency is a nutritional condition produced by a deficiency of vitamin D in the diet, insufficient production of vitamin D in the skin, inadequate absorption of vitamin D from the diet, or abnormal conversion of vitamin D to its bioactive metabolites. It is manifested clinically as rickets in children and osteomalacia in adults. (National Library of Medicine) [e]
- Breast cancer [r]: Cancer of the glandular breast tissue. [e]
- Hydroxymethylglutaryl-coenzyme A reductase inhibitor [r]: HMG-CoA reductase inhibitors which reduce 3-hydroxy-3-methyl-glutaryl CoA and lower cholesterol synthesis. [e]
- Coronary heart disease [r]: Disease of the heart that involves narrowing of the coronary arteries. [e]